Regional lender shares tumble as Fed persists with rate hikes in spite of field turmoil

Regional lender shares tumble as Fed persists with rate hikes in spite of field turmoil


Important Points
  • Regional banks ended Wednesday down as traders regarded as the wellness of the banking process pursuing the Federal Reserve conference.
  • The SPDR S&P Regional Bank ETF (KRE) reached a new session reduced in the course of Chair Jerome Powell’s push meeting and slid more heading into the market’s near.



Resource

Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more

Check out the companies making headlines before the bell: Novo Nordisk — The maker of obesity drug Wegovy’s U.S. stock fell about 13% after unexpectedly warning that fiscal 2026 sales will be hurt by lower drug prices in the U.S. even as it anticipates more patients will use its popular GLP-1 drug. Novo Nordisk said […]

Read More
Rocket Companies shares jump 6% after CEO says mortgage loan volume is surging
Finance

Rocket Companies shares jump 6% after CEO says mortgage loan volume is surging

In this article RKT Follow your favorite stocksCREATE FREE ACCOUNT watch now VIDEO8:4108:41 Rocket Companies CEO: On track to produce the highest mortgage loan production in 4 years Squawk Box Rocket Companies shares jumped on Tuesday after CEO Varun Krishna told CNBC the company was writing a larger amount of mortgage loans. “We’re getting ready […]

Read More
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more
Finance

Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more

Check out the companies making headlines before the bell: Palantir — The stock jumped 11% following the AI-powered software provider’s fourth-quarter earnings beat . Palantir reported adjusted earnings of 25 cents per share, versus the 23 cents expected from analysts polled by LSEG. Revenue was $1.41 billion, topping the $1.33 billion consensus estimate. Merck — […]

Read More